Innate Pharma S.A. (ADR)
General ticker "IPHA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $157.7M (TTM average)
Innate Pharma S.A. (ADR) does not follow the US Stock Market performance with the rate: -5.3%.
Estimated limits based on current volatility of 3.5%: low 1.74$, high 1.82$
Factors to consider:
- Total employees count: 235 as of 2019
Short-term IPHA quotes
Long-term IPHA plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | €12.62MM | €2.79MM |
| Operating Expenses | €64.20MM | €56.21MM |
| Operating Income | €-51.58MM | €-53.42MM |
| Non-Operating Income | €2.10MM | €4.25MM |
| Interest Expense | €0.57MM | €0.44MM |
| R&D Expense | €51.98MM | €43.62MM |
| Income(Loss) | €-49.47MM | €-49.18MM |
| Net Income(Loss)* | €-49.47MM | €-51.12MM |
| Stockholders Equity | €8.83MM | €-21.69MM |
| Assets | €111.06MM | €62.69MM |
| Operating Cash Flow | €-6.90MM | €-50.67MM |
| Capital expenditure | €0.39MM | €0.13MM |
| Investing Cash Flow | €9.20MM | €7.00MM |
| Financing Cash Flow | €-6.01MM | €5.83MM |
| Earnings Per Share** | €-0.61 | €-0.57 |
| Ordinary share to ADR | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.